p|datav0.1news209
HomeMarketsNews209MapMonitor
menu
HomeMarketsNews209MapMonitor
theme
pdata/markets/Will the FDA approve camizestrant for advanced breast cancer?

Will the FDA approve camizestrant for advanced breast cancer?

Source: kalshi·Event ID: KXFDAAPPROVE-CAM·Ends: 1/8/2028

Markets

  • Before Jan 1, 2027

    • Yes: 66¢
    • No: 34¢
  • Before Jul 1, 2026

    • Yes: 27¢
    • No: 73¢
  • Before Oct 1, 2026

    • Yes: 4¢
    • No: 96¢
  • Before Jun 1, 2026

    • Yes: 1¢
    • No: 99¢
  • Before Jan 1, 2028

    • Yes: 76¢
    • No: 24¢
p|data·synced:Polymarket—Kalshi—Manifold—Predict—Myriad—Opinion—Limitless—Gemini—
aboutmethodologyagentsdocsx© 2026